quest healthcare injectables limited
quest healthcare injectables limited Company Information
Company Number
08679526
Website
-Registered Address
alexander house, 60-61 tenby street north, birmingham, B1 3EG
Industry
Manufacture of pharmaceutical preparations
Telephone
01213266411
Next Accounts Due
June 2025
Group Structure
View All
Directors
Yasar Hussain11 Years
Shareholders
majad hussain 100%
quest healthcare injectables limited Estimated Valuation
Pomanda estimates the enterprise value of QUEST HEALTHCARE INJECTABLES LIMITED at £3.9k based on a Turnover of £4.3k and 0.91x industry multiple (adjusted for size and gross margin).
quest healthcare injectables limited Estimated Valuation
Pomanda estimates the enterprise value of QUEST HEALTHCARE INJECTABLES LIMITED at £0 based on an EBITDA of £0 and a 3.98x industry multiple (adjusted for size and gross margin).
quest healthcare injectables limited Estimated Valuation
Pomanda estimates the enterprise value of QUEST HEALTHCARE INJECTABLES LIMITED at £0 based on Net Assets of £-474 and 2.51x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Quest Healthcare Injectables Limited Overview
Quest Healthcare Injectables Limited is a live company located in birmingham, B1 3EG with a Companies House number of 08679526. It operates in the manufacture of pharmaceutical preparations sector, SIC Code 21200. Founded in September 2013, it's largest shareholder is majad hussain with a 100% stake. Quest Healthcare Injectables Limited is a established, micro sized company, Pomanda has estimated its turnover at £4.3k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Quest Healthcare Injectables Limited Health Check
Pomanda's financial health check has awarded Quest Healthcare Injectables Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs
1 Strong
1 Regular
7 Weak
Size
annual sales of £4.3k, make it smaller than the average company (£24m)
- Quest Healthcare Injectables Limited
£24m - Industry AVG
Growth
3 year (CAGR) sales growth of -5%, show it is growing at a slower rate (5.2%)
- Quest Healthcare Injectables Limited
5.2% - Industry AVG
Production
with a gross margin of 14.7%, this company has a higher cost of product (32.9%)
- Quest Healthcare Injectables Limited
32.9% - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Quest Healthcare Injectables Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (94)
- Quest Healthcare Injectables Limited
94 - Industry AVG
Pay Structure
on an average salary of £56.1k, the company has an equivalent pay structure (£56.1k)
- Quest Healthcare Injectables Limited
£56.1k - Industry AVG
Efficiency
resulting in sales per employee of £4.3k, this is less efficient (£241.7k)
- Quest Healthcare Injectables Limited
£241.7k - Industry AVG
Debtor Days
it gets paid by customers after 82 days, this is later than average (58 days)
- Quest Healthcare Injectables Limited
58 days - Industry AVG
Creditor Days
its suppliers are paid after 144 days, this is slower than average (40 days)
- Quest Healthcare Injectables Limited
40 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Quest Healthcare Injectables Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Quest Healthcare Injectables Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 148.8%, this is a higher level of debt than the average (46.8%)
148.8% - Quest Healthcare Injectables Limited
46.8% - Industry AVG
QUEST HEALTHCARE INJECTABLES LIMITED financials
Quest Healthcare Injectables Limited's latest turnover from September 2023 is estimated at £4.3 thousand and the company has net assets of -£474. According to their latest financial statements, we estimate that Quest Healthcare Injectables Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||
| Other Income Or Grants | ||||||||||
| Cost Of Sales | ||||||||||
| Gross Profit | ||||||||||
| Admin Expenses | ||||||||||
| Operating Profit | ||||||||||
| Interest Payable | ||||||||||
| Interest Receivable | ||||||||||
| Pre-Tax Profit | ||||||||||
| Tax | ||||||||||
| Profit After Tax | ||||||||||
| Dividends Paid | ||||||||||
| Retained Profit | ||||||||||
| Employee Costs | ||||||||||
| Number Of Employees | ||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 971 | 971 | 971 | 971 | 971 | 971 | 1 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 971 | 971 | 971 | 971 | 971 | 971 | 1 | 0 | 0 | 0 |
| total assets | 971 | 971 | 971 | 971 | 971 | 971 | 1 | 0 | 0 | 0 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 1,445 | 1,445 | 1,445 | 1,445 | 1,445 | 1,445 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 1,445 | 1,445 | 1,445 | 1,445 | 1,445 | 1,445 | 0 | 0 | 0 | 0 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 1,445 | 1,445 | 1,445 | 1,445 | 1,445 | 1,445 | 0 | 0 | 0 | 0 |
| net assets | -474 | -474 | -474 | -474 | -474 | -474 | 1 | 0 | 0 | 0 |
| total shareholders funds | -474 | -474 | -474 | -474 | -474 | -474 | 1 | 0 | 0 | 0 |
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Operating Profit | ||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Tax | ||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | 0 | 0 | 0 | 0 | 970 | 1 | 0 | 0 | 0 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 1,445 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||
| Investing Activities | ||||||||||
| capital expenditure | ||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||
| Financing Activities | ||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||
| interest | ||||||||||
| cash flow from financing | ||||||||||
| cash and cash equivalents | ||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
quest healthcare injectables limited Credit Report and Business Information
Quest Healthcare Injectables Limited Competitor Analysis
Perform a competitor analysis for quest healthcare injectables limited by selecting its closest rivals, whether from the MANUFACTURING sector, other micro companies, companies in B 1 area or any other competitors across 12 key performance metrics.
quest healthcare injectables limited Ownership
QUEST HEALTHCARE INJECTABLES LIMITED group structure
Quest Healthcare Injectables Limited has no subsidiary companies.
Ultimate parent company
QUEST HEALTHCARE INJECTABLES LIMITED
08679526
quest healthcare injectables limited directors
Quest Healthcare Injectables Limited currently has 1 director, Mr Yasar Hussain serving since Sep 2013.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Yasar Hussain | United Kingdom | 48 years | Sep 2013 | - | Director |
P&L
September 2023turnover
4.3k
-3%
operating profit
0
0%
gross margin
14.7%
-44.44%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2023net assets
-474
0%
total assets
971
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
quest healthcare injectables limited company details
company number
08679526
Type
Private limited with Share Capital
industry
21200 - Manufacture of pharmaceutical preparations
incorporation date
September 2013
age
11
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
September 2023
previous names
N/A
accountant
-
auditor
-
address
alexander house, 60-61 tenby street north, birmingham, B1 3EG
Bank
-
Legal Advisor
-
quest healthcare injectables limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to quest healthcare injectables limited.
quest healthcare injectables limited Companies House Filings - See Documents
| date | description | view/download |
|---|
